New vaccine targets Hepatitis B eradication

“Aug. 5 – Israeli drug company SciVac has developed a third-generation vaccine for Hepatitis B, a virus that kills more than half a million people each year. The company says the vaccine has the potential to stop the disease in its tracks and is currently seeking approval for its use in the United States and Europe. Elly Park reports.” Source: ReutersVideo

Leave a Reply

Your email address will not be published. Required fields are marked *